[Management of antibiotics in regard of procalcitonin levels: PRORATA trial (PROcalcitonin to Reduce Antibiotic Treatments in Acutely ill patients)]

[Article in German]

Affiliations

¹ Infektionsabteilung, Medizinische Poliklinik-Innenstadt, Klinikum der Universität München, Lindwurmstraße 2a, Munich, Germany. Hanne.Myska@med.uni-muenchen.de

Comment

[Article in German]

J Bogner et al. Internist (Berl). 2010 Dec.

. 2010 Dec;51(12):1582-4.

doi: 10.1007/s00108-010-2748-5.

¹ Infektionsabteilung, Medizinische Poliklinik-Innenstadt, Klinikum der Universität München, Lindwurmstraße 2a, Munich, Germany. Hanne.Myska@med.uni-muenchen.de

No abstract available

Comment on

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Régnier B, Brun-Buisson C, Chastre J, Wolff M; PRORATA trial group. Bouadma L, et al. Lancet. 2010 Feb 6;375(9713):463-74. doi: 10.1016/S0140-6736(09)61879-1. Epub 2010 Jan 25. Lancet. 2010. PMID: 20097417 Clinical Trial.